闪光东本
发表于 2025-3-23 10:06:03
Submitted on: 06 March 2010.
Revised on: 14 April 2010.
Accepted on: 25 April 2010.
PERFORMANCE EVALUATION---ELSEVIER
截断
发表于 2025-3-23 15:41:06
Submitted on: 02 April 1998.
Revised on: 16 April 1998.
Accepted on: 02 May 1998.
PERFORMANCE EVALUATION
欢笑
发表于 2025-3-23 20:08:28
http://reply.papertrans.cn/3/243/24257/24257-13.png
d-limonene
发表于 2025-3-23 22:15:34
Submitted on: 20 April 2021.
Revised on: 30 May 2021.
Accepted on: 10 June 2021.
PERFORMANCE EVALUATION---ELSEVIER
LIMIT
发表于 2025-3-24 06:18:14
Submitted on: 24 September 2015.
Revised on: 18 October 2015.
Accepted on: 08 November 2015.
PERFORMANCE EVALUATION
国家明智
发表于 2025-3-24 07:26:10
Submitted on: 14 March 2022.
Revised on: 02 April 2022.
Accepted on: 11 April 2022.
PERFORMANCE EVALUATION---ELSEVIER
Retrieval
发表于 2025-3-24 13:42:24
http://reply.papertrans.cn/3/243/24257/24257-17.png
吼叫
发表于 2025-3-24 17:10:05
http://reply.papertrans.cn/3/243/24257/24257-18.png
spondylosis
发表于 2025-3-24 19:52:22
Submitted on: 19 November 2014.
Revised on: 27 November 2014.
Accepted on: 23 December 2014.
PERFORMANCE EVALUATION---ELSEVIER
carotenoids
发表于 2025-3-25 02:25:47
Submitted on: 03 October 2008.
Revised on: 19 October 2008.
Accepted on: 02 November 2008.
PERFORMANCE EVALUATION